TDP-43: an emerging new player in neurodegenerative diseases

Trends in Molecular Medicine

Volumn 14, Issue 11, 2008, Pages 479-485

  Wang, I Fan ^a   Wu, Lien Szu ^a   Shen, C K James ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TAR DNA BINDING PROTEIN 43; TAU PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CORTEX ATROPHY; CELL INCLUSION; CELLULAR DISTRIBUTION; FRONTAL CORTEX; GLIA CELL; HUMAN; METABOLIC DISORDER; MOLECULAR MODEL; NERVE CELL; NERVE CELL CULTURE; NEUROPATHOLOGY; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN STRUCTURE; TEMPORAL CORTEX; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NEURODEGENERATIVE DISEASES; NEURONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 54249100481     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2008.09.001     Document Type: Article

References (87)

1. Wang H.Y., et al. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83 (2004) 130-139
2. Ou S.H., et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69 (1995) 3584-3596
3. Wang I.F., et al. Higher order arrangement of the eukaryotic nuclear bodies. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13583-13588
4. Buratti E., et al. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20 (2001) 1774-1784
5. Mercado P.A., et al. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res. 33 (2005) 6000-6010
6. Bose, J.K. et al. TDP-43 overexpression enhances exon-7 inclusion during SMN pre-mRNA splicing. J. Biol. Chem. (in press)
7. Arai T., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 (2006) 602-611
8. Neumann M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
9. Neumann M., et al. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch. Neurol. 64 (2007) 1388-1394
10. Buratti E., and Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276 (2001) 36337-36343
11. Buratti E., et al. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280 (2005) 37572-37584
12. Winton M.J., et al. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283 (2008) 13302-13309
13. Zhang Y.J., et al. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27 (2007) 10530-10534
14. Abhyankar M.M., et al. A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues: role for TDP-43 in insulator function. J. Biol. Chem. 282 (2007) 36143-36154
15. Lehner B., and Sanderson C.M. A protein interaction framework for human mRNA degradation. Genome Res. 14 (2004) 1315-1323
16. Kim M., et al. The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II. Nature 432 (2004) 517-522
17. Luo W., et al. The role of Rat1 in coupling mRNA 3′-end processing to transcription termination: implications for a unified allosteric-torpedo model. Genes Dev. 20 (2006) 954-965
18. Schultz D.C., et al. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16 (2002) 919-932
19. Malik S., et al. The U. S. A. -derived transcriptional coactivator PC2 is a submodule of TRAP/SMCC and acts synergistically with other PCs. Mol. Cell 5 (2000) 753-760
20. Sato S., et al. A mammalian homolog of Drosophila melanogaster transcriptional coactivator intersex is a subunit of the mammalian Mediator complex. J. Biol. Chem. 278 (2003) 49671-49674
21. Shou Z., et al. Genomic structure and analysis of transcriptional regulation of the mouse zinc-fingers and homeoboxes 1 (ZHX1) gene. Gene 302 (2003) 83-94
22. West S., et al. Human 5′ → 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites. Nature 432 (2004) 522-525
23. Custodio N., et al. Splicing- and cleavage-independent requirement of RNA polymerase II CTD for mRNA release from the transcription site. J. Cell Biol. 179 (2007) 199-207
24. Snowden J.S., et al. Frontotemporal dementia. Br. J. Psychiatry 180 (2002) 140-143
25. Pickering-Brown S.M. The complex aetiology of frontotemporal lobar degeneration. Exp. Neurol. 206 (2007) 1-10
26. Cairns N.J., et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 171 (2007) 227-240
27. Lomen-Hoerth C., et al. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59 (2002) 1077-1079
28. Murphy J., et al. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch. Neurol. 64 (2007) 330-334
29. Murphy J.M., et al. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch. Neurol. 64 (2007) 530-534
30. Mackenzie I.R., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61 (2007) 427-434
31. Amador-Ortiz C., et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61 (2007) 435-445
32. Uryu K., et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J. Neuropathol. Exp. Neurol. 67 (2008) 555-564
33. Higashi S., et al. Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184 (2007) 284-294
34. Nakashima-Yasuda H., et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114 (2007) 221-229
35. Hasegawa M., et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130 (2007) 1386-1394
36. Geser F., et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 115 (2008) 133-145
37. Probst A., et al. Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol. 114 (2007) 335-345
38. Forman M.S., et al. TDP-43: a novel neurodegenerative proteinopathy. Curr. Opin. Neurobiol. 17 (2007) 548-555
39. Snowden J., et al. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 114 (2007) 31-38
40. Banks G.T., et al. TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander. Mamm. Genome 19 (2008) 299-305
41. Liscic R.M., et al. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur. J. Neurol. 15 (2008) 772-780
42. Guinto J.B., et al. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy. Acta Neuropathol. 114 (2007) 55-61
43. Kwong L.K., et al. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol. 114 (2007) 63-70
44. Mackenzie I.R. The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol. 114 (2007) 49-54
45. Mackenzie I.R., and Rademakers R. The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics 8 (2007) 237-248
46. Kwong L.K., et al. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals 16 (2008) 41-51
47. Pickering-Brown S.M. Progranulin and frontotemporal lobar degeneration. Acta Neuropathol. 114 (2007) 39-47
48. Cairns N.J., et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114 (2007) 5-22
49. Davidson Y., et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol. 113 (2007) 521-533
50. Wang I.F., et al. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J. Neurochem. 105 (2008) 797-806
51. Filimonenko M., et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 179 (2007) 485-500
52. Skibinski G., et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37 (2005) 806-808
53. Parkinson N., et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67 (2006) 1074-1077
54. Johnson B.S., et al. A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 6439-6444
55. Dubnau J., et al. The staufen/pumilio pathway is involved in Drosophila long-term memory. Curr. Biol. 13 (2003) 286-296
56. Martin K.C., et al. Local protein synthesis and its role in synapse-specific plasticity. Curr. Opin. Neurobiol. 10 (2000) 587-592
57. Sutton M.A., and Schuman E.M. Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127 (2006) 49-58
58. Ule J., and Darnell R.B. RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr. Opin. Neurobiol. 16 (2006) 102-110
59. Govindarajan A., et al. A clustered plasticity model of long-term memory engrams. Nat. Rev. Neurosci. 7 (2006) 575-583
60. Lein E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445 (2007) 168-176
61. Ferrari F., et al. The fragile X mental retardation protein-RNP granules show an mGluR-dependent localization in the post-synaptic spines. Mol. Cell. Neurosci. 34 (2007) 343-354
62. Villace P., et al. The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res. 32 (2004) 2411-2420
63. Elvira G., et al. Characterization of an RNA granule from developing brain. Mol. Cell. Proteomics 5 (2006) 635-651
64. Barbee S.A., et al. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 52 (2006) 997-1009
65. Parker R., and Sheth U. P bodies and the control of mRNA translation and degradation. Mol. Cell 25 (2007) 635-646
66. Gregory R.I., et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 432 (2004) 235-240
67. Wu G.Y., et al. Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology. Nat. Neurosci. 4 (2001) 151-158
68. Miller S., et al. Disruption of dendritic translation of CaMKIIα impairs stabilization of synaptic plasticity and memory consolidation. Neuron 36 (2002) 507-519
69. Gijselinck I., et al. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol. Aging (2007). http://www.sciencedirect.com/science/journal/01974580 10.1016/j.neurobiolaging.2007.11.002
70. Rollinson S., et al. TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci. Lett. 419 (2007) 1-4
71. Schumacher A., et al. No association of TDP-43 with sporadic frontotemporal dementia. Neurobiol. Aging (2007). http://www.sciencedirect.com/science/journal/01974580 10.1016/j.neurobiolaging.2007.05.022
72. Gitcho M.A., et al. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 63 (2008) 535-538
73. Kabashi E., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40 (2008) 572-574
74. Sreedharan J., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (2008) 1668-1672
75. Van Deerlin V.M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7 (2008) 409-416
76. Yokoseki A., et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 63 (2008) 538-542
77. Igaz L.M., et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 173 (2008) 182-194
78. Gilks N., et al. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol. Biol. Cell 15 (2004) 5383-5398
79. Li S.H., and Li X.J. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 20 (2004) 146-154
80. Sato S., et al. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol. Cell 14 (2004) 685-691
81. Stelzl U., et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 122 (2005) 957-968
82. Neumann M., et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J. Neuropathol. Exp. Neurol. 66 (2007) 177-183
83. Neumann M., et al. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 66 (2007) 152-157
84. Zhang H., et al. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 115 (2008) 115-122
85. Mackenzie I.R., et al. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 131 (2008) 1282-1293
86. Roeber S., et al. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol. 116 (2008) 147-157
87. Hasegawa M., et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64 (2008) 60-70